Related Experiment Video
Updated: Jun 1, 2026

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
Chorioamnionitis: from pathogenesis to treatment
M J Czikk1, F P McCarthy, K E Murphy
1Department of Obstetrics and Gynaecology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada. mczikk@mtsinai.on.ca
Abstract:
Chorioamnionitis refers to inflammation of the amniochorionic membrane, and is a significant cause of maternal and neonatal morbidity. Chorioamnionitis most often occurs as a result of ascending infection, and is commonly associated with premature rupture of the membranes. Chorioamnionitis is generally the result of a polymicrobial infection, with Ureaplasma urealyticum, Mycoplasma hominis and Gram-negative anaerobes being frequent causative organisms. The mainstay of treatment includes antimicrobial agents, antipyretics, expedition of delivery and supportive care. Further research is required to identify mechanistic pathways and early biomarkers that accurately predict women at higher risk of adverse maternal and neonatal outcomes, and that can thus lead to the development of additional treatment and prevention strategies.
Insights
Chorioamnionitis, an infection causing maternal and neonatal illness, often results from ascending infections and premature rupture of membranes. New biomarkers are needed for early risk prediction and improved treatment strategies.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Neonatology
Background:
- Chorioamnionitis is inflammation of the amniochorionic membrane.
- It is a major cause of maternal and neonatal morbidity.
- Often linked to ascending infections and premature rupture of membranes.
Purpose of the Study:
- To review the causes, consequences, and current management of chorioamnionitis.
- To highlight the need for improved diagnostic and therapeutic approaches.
Main Methods:
- Literature review of chorioamnionitis.
- Analysis of causative organisms and treatment modalities.
Main Results:
- Chorioamnionitis is frequently polymicrobial, with common pathogens including Ureaplasma urealyticum, Mycoplasma hominis, and Gram-negative anaerobes.
- Current treatments involve antimicrobials, antipyretics, expedited delivery, and supportive care.
Conclusions:
- Further research is essential to identify early biomarkers for risk prediction.
- Developing novel treatment and prevention strategies is crucial for better maternal and neonatal outcomes.
Related Concept Videos
Trichomoniasis
Acute Pyelonephritis II: Diagnostic Studies and Management
Streptococcal Pharyngitis
Acute Pyelonephritis I: Introduction
Urinary Tract Infection II: Pathophysiology
Acute Pancreatitis II: Clinical Manifestations and Management